Novartis AG (NVS) stock saw a modest uptick, ending the day at $105.48 which represents a slight increase of $0.76 or 0.73% from the prior close of $104.72. The stock opened at $104.47 and touched a ...

Chicago Partners Investment Group LLC bought a new stake in shares of Novartis AG (NYSE:NVS – Free Report) during the 4th ...

CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if ...

Incyte Corporation INCY is scheduled to report fourth-quarter and full-year 2024 results on Feb. 10, before the opening bell.

Novartis UK announced the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised ribociclib for adjuvant ...

The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...

The Delhi High Court on February 3 passed an interim injunction restraining a pharmaceutical company from using the trademark ...

Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.

The company expects its operating margin to reach 16% in the first three months of the year, down from the 26.4% it posted in the same period in 2024. "While customer inventory corrections are ...

A Weibo post from the company confirmed that the Realme GT 7 Pro Racing Edition will launch in China in February this year. The exact launch date has yet to be announced. No other details about the ...

Majority of leaders in life sciences -- pharmaceutical and medical technology companies -- and high-tech companies like semiconductor, electronic component, and original equipment manufacturing are ...

The partial failure of its NVS-02 navigation satellite on Sunday was the latest in a series of setbacks suffered by the ...